FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898494075> ?p ?o ?g. }

• W2898494075 endingPage "1016" @default.
• W2898494075 startingPage "1010" @default.
• W2898494075 abstract "Background Although patients with chronic rhinosinusitis without nasal polyps (CRSsNP) represent a majority of the chronic rhinosinusitis (CRS) population, they have not been completely characterized phenotypically. Objective To perform a comprehensive phenotypic characterization of subjects with CRSsNP, using CRS with nasal polyps (CRSwNP) as a comparator. Methods Patients with a history of CRS with positive sinus computed tomography (>18 years old) evaluated in the allergy/immunology or otolaryngology clinics of an academic center between 2002 and 2012 were identified via International Classification of Diseases, Ninth Revision codes. A retrospective chart review was performed on a subset of 507 patients with CRSsNP and 874 with CRSwNP. Characteristics analyzed included demographics, comorbid conditions, and radiologic sinus severity. Results Of the total CRS population, approximately 82% had CRSsNP and 18% had CRSwNP. Of the 507 patients in the CRSsNP group, 319 (63%) were female compared with 393 of 847 (45%) in the CRSwNP group. The prevalence of atopy was 52% in CRSsNP versus 76% in CRSwNP (P < .0001). In CRSsNP, atopic patients had more severe radiographic disease compared with nonatopic patients (P < .005). The prevalence of asthma was 36% in CRSsNP versus 56% in CRSwNP (P < .0001). Comorbid asthma was not associated with radiographic sinus disease severity in CRSsNP but was associated with severity in CRSwNP (P < .0001). Conclusions The relative prevalence of CRS phenotypes in the western population is approximately 80% CRSsNP and 20% CRSwNP. Patients with CRSsNP were predominantly female, whereas patients with CRSwNP were predominantly male. The prevalence of asthma was higher in our cohort of patients with CRSsNP than previously described. Atopy was associated with more severe radiographic sinonasal disease in CRSsNP, whereas asthma was not associated with radiographic sinonasal disease severity. Although patients with chronic rhinosinusitis without nasal polyps (CRSsNP) represent a majority of the chronic rhinosinusitis (CRS) population, they have not been completely characterized phenotypically. To perform a comprehensive phenotypic characterization of subjects with CRSsNP, using CRS with nasal polyps (CRSwNP) as a comparator. Patients with a history of CRS with positive sinus computed tomography (>18 years old) evaluated in the allergy/immunology or otolaryngology clinics of an academic center between 2002 and 2012 were identified via International Classification of Diseases, Ninth Revision codes. A retrospective chart review was performed on a subset of 507 patients with CRSsNP and 874 with CRSwNP. Characteristics analyzed included demographics, comorbid conditions, and radiologic sinus severity. Of the total CRS population, approximately 82% had CRSsNP and 18% had CRSwNP. Of the 507 patients in the CRSsNP group, 319 (63%) were female compared with 393 of 847 (45%) in the CRSwNP group. The prevalence of atopy was 52% in CRSsNP versus 76% in CRSwNP (P < .0001). In CRSsNP, atopic patients had more severe radiographic disease compared with nonatopic patients (P < .005). The prevalence of asthma was 36% in CRSsNP versus 56% in CRSwNP (P < .0001). Comorbid asthma was not associated with radiographic sinus disease severity in CRSsNP but was associated with severity in CRSwNP (P < .0001). The relative prevalence of CRS phenotypes in the western population is approximately 80% CRSsNP and 20% CRSwNP. Patients with CRSsNP were predominantly female, whereas patients with CRSwNP were predominantly male. The prevalence of asthma was higher in our cohort of patients with CRSsNP than previously described. Atopy was associated with more severe radiographic sinonasal disease in CRSsNP, whereas asthma was not associated with radiographic sinonasal disease severity." @default.
• W2898494075 created "2018-11-02" @default.
• W2898494075 creator A5028761825 @default.
• W2898494075 creator A5045386706 @default.
• W2898494075 creator A5047671590 @default.
• W2898494075 creator A5053008699 @default.
• W2898494075 creator A5053082544 @default.
• W2898494075 creator A5054391702 @default.
• W2898494075 creator A5056666751 @default.
• W2898494075 creator A5057729731 @default.
• W2898494075 creator A5070705978 @default.
• W2898494075 creator A5072499672 @default.
• W2898494075 creator A5078740971 @default.
• W2898494075 creator A5085628613 @default.
• W2898494075 date "2019-03-01" @default.
• W2898494075 modified "2023-10-12" @default.
• W2898494075 title "Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting" @default.
• W2898494075 cites W1275055896 @default.
• W2898494075 cites W1597838084 @default.
• W2898494075 cites W1606887512 @default.
• W2898494075 cites W1970196744 @default.
• W2898494075 cites W1975646629 @default.
• W2898494075 cites W1977598581 @default.
• W2898494075 cites W1982941253 @default.
• W2898494075 cites W2001598351 @default.
• W2898494075 cites W2010668367 @default.
• W2898494075 cites W2011991479 @default.
• W2898494075 cites W2013100340 @default.
• W2898494075 cites W2036507101 @default.
• W2898494075 cites W2036867429 @default.
• W2898494075 cites W2052137119 @default.
• W2898494075 cites W2053159571 @default.
• W2898494075 cites W2068223656 @default.
• W2898494075 cites W2074244664 @default.
• W2898494075 cites W2078744808 @default.
• W2898494075 cites W2116466766 @default.
• W2898494075 cites W2157779085 @default.
• W2898494075 cites W2173384521 @default.
• W2898494075 cites W2221351268 @default.
• W2898494075 cites W2275028388 @default.
• W2898494075 cites W2289316671 @default.
• W2898494075 cites W2324417905 @default.
• W2898494075 cites W2460887888 @default.
• W2898494075 cites W2517035143 @default.
• W2898494075 cites W2519161146 @default.
• W2898494075 cites W2567558689 @default.
• W2898494075 cites W2594220482 @default.
• W2898494075 cites W2993259418 @default.
• W2898494075 cites W3023508199 @default.
• W2898494075 cites W4233854517 @default.
• W2898494075 cites W4239218095 @default.
• W2898494075 doi "https://doi.org/10.1016/j.jaip.2018.10.014" @default.
• W2898494075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6862765" @default.
• W2898494075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30368005" @default.
• W2898494075 hasPublicationYear "2019" @default.
• W2898494075 type Work @default.
• W2898494075 sameAs 2898494075 @default.
• W2898494075 citedByCount "65" @default.
• W2898494075 countsByYear W28984940752019 @default.
• W2898494075 countsByYear W28984940752020 @default.
• W2898494075 countsByYear W28984940752021 @default.
• W2898494075 countsByYear W28984940752022 @default.
• W2898494075 countsByYear W28984940752023 @default.
• W2898494075 crossrefType "journal-article" @default.
• W2898494075 hasAuthorship W2898494075A5028761825 @default.
• W2898494075 hasAuthorship W2898494075A5045386706 @default.
• W2898494075 hasAuthorship W2898494075A5047671590 @default.
• W2898494075 hasAuthorship W2898494075A5053008699 @default.
• W2898494075 hasAuthorship W2898494075A5053082544 @default.
• W2898494075 hasAuthorship W2898494075A5054391702 @default.
• W2898494075 hasAuthorship W2898494075A5056666751 @default.
• W2898494075 hasAuthorship W2898494075A5057729731 @default.
• W2898494075 hasAuthorship W2898494075A5070705978 @default.
• W2898494075 hasAuthorship W2898494075A5072499672 @default.
• W2898494075 hasAuthorship W2898494075A5078740971 @default.
• W2898494075 hasAuthorship W2898494075A5085628613 @default.
• W2898494075 hasBestOaLocation W28984940752 @default.
• W2898494075 hasConcept C126322002 @default.
• W2898494075 hasConcept C203014093 @default.
• W2898494075 hasConcept C207480886 @default.
• W2898494075 hasConcept C2776042228 @default.
• W2898494075 hasConcept C2777697326 @default.
• W2898494075 hasConcept C2777768476 @default.
• W2898494075 hasConcept C2779159551 @default.
• W2898494075 hasConcept C2781390199 @default.
• W2898494075 hasConcept C2908647359 @default.
• W2898494075 hasConcept C3019717275 @default.
• W2898494075 hasConcept C71924100 @default.
• W2898494075 hasConcept C72563966 @default.
• W2898494075 hasConcept C99454951 @default.
• W2898494075 hasConceptScore W2898494075C126322002 @default.
• W2898494075 hasConceptScore W2898494075C203014093 @default.
• W2898494075 hasConceptScore W2898494075C207480886 @default.
• W2898494075 hasConceptScore W2898494075C2776042228 @default.
• W2898494075 hasConceptScore W2898494075C2777697326 @default.
• W2898494075 hasConceptScore W2898494075C2777768476 @default.
• W2898494075 hasConceptScore W2898494075C2779159551 @default.
• W2898494075 hasConceptScore W2898494075C2781390199 @default.

• next